Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

GSK 1,393.58 +4.58 (0.33%)
price chart
US top court rules for Glaxo on overtime pay
By a 5-4 vote, the high court handed a defeat to two former sales representatives for a unit of Britain's GlaxoSmithKline Plc. They had appealed a U.S. appeals court in California ruling that they were "outside sales" personnel exempt from federal ...
GSK Receives FDA Approval for MenHibrix�
PHILADELPHIA, June 14, 2012 /PRNewswire/ -- GlaxoSmithKline plc (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix� [Meningococcal Groups C and Y and Haemophilus b Tetanus ...
US approves Glaxo meningitis vaccine for children  Fox News
KineMed Announces Biomarker Discovery Collaboration with GSK
EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today a multi-year R&D collaboration with GlaxoSmithKline plc (GSK) (LSE: GSK, NYSE: GSK) that will apply KineMed's proprietary biomarker discovery platform in ...
Glaxo Gene-Blocking Melanoma Drugs Beat Chemotherapy in Studies
June 4 (Bloomberg) -- Two experimental GlaxoSmithKline Plc drugs that block genes tied to lethal skin cancer worked better than chemotherapy in studies that tested them individually, paving the way for final-phase trials on their use together.
Glaxo, Novartis to get US contracts to make vaccines
WASHINGTON Pharmaceutical companies including GlaxoSmithKline PLC and Novartis AG will get federal money to help develop medicines against pandemics and bioterrorist threats, the U.S.
Glaxo to Pay at Least $226 Million for Basilea's Toctino
June 12 (Bloomberg) -- GlaxoSmithKline Plc agreed to buy the marketing rights for Basilea Pharmaceutica AG's hand eczema drug Toctino for 146 million pounds ($226 million).
Glaxo CEO Says Europe Market 'Much' Worse Than Expected
GlaxoSmithKline Plc Chief Executive Officer Andrew Witty said, “What we've seen in the last three, four months is a much higher level of price pressure than we had anticipated, which is of course making short-term trading more challenging than expected.
FDA approves XenoPort, GSK's Horizant ER tablets for management of PHN
GlaxoSmithKline plc (GSK) and XenoPort, Inc. (Nasdaq:XNPT) announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant� (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic ...
Should investors embrace the profits of sin?
Investors are equally divided on another key component of the Saints: pharmaceuticals companies. GlaxoSmithKline (GSK) and AstraZeneca (AZN) are among the highest-yielding companies in the FTSE 100, yet the rising cost of drug discoveries coupled ...
Bristol, AstraZeneca among Amylin bidders-sources
O), and a bid by GlaxoSmithKline Plc (GSK.L) to buy long-time partner Human Genome Sciences Inc HGSI.O for about $2.6 billion.